Dietary Neuroketotherapeutics for Alzheimer’s Disease: An Evidence Update and the Potential Role for Diet Quality

Dietary Neuroketotherapeutics for Alzheimer’s Disease: An Evidence Update and the Potential Role for Diet Quality

Alzheimer’s disease (AD) is a devastating neurodegenerative disease with growing prevalence as the global population ages. Currently available treatments for AD have minimal efficacy and there are no proven treatments for its prodrome, mild cognitive impairment (MCI). AD etiology is not we...

Full description

Bibliographic Details
Main Authors: Matthew K. Taylor, Russell H. Swerdlow, Debra K. Sullivan
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Nutrients
Subjects:
neuroketotherapeutics
Alzheimer’s disease
cognition
fasting
ketogenic diet
β-hydroxybutyrate
medium-chain triglyceride
bioenergetics
diet quality
Online Access:https://www.mdpi.com/2072-6643/11/8/1910

Similar Items

Similar Items